Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Web Exclusives

Infections in Patients with CLL Receiving Ibrutinib
Web Exclusives — November 17, 2021
Identifying the risk factors for infection may allow preventive measures to be taken to protect patients. Read More ›

Measuring Treatment Adherence to Oral Therapies in Patients with CLL
Web Exclusives — November 17, 2021
Oral targeted therapies have revolutionized treatment for patients with CLL but ensuring that they are taken as prescribed is crucial to achieving optimal outcomes. Read More ›

Recent Regulation of Copay Adjustment Programs
Web Exclusives — November 17, 2021
Copay assistance coupons and copay adjustment programs put patients in the middle of healthcare cost-saving measures. Read More ›

Welcome to the Multiple Myeloma Resource Navigator for Patients
Web Exclusives — November 16, 2021
This publication was created together with leading patient advocates who shared their experiences and insights, in the hope that it will help you connect with patient organizations and resources as you and your care partners navigate through your diagnosis and treatment. These patient organizations provide education and support to promote your health and well-being, and help with practical matters, logistics, and financial and legal concerns. Read More ›

Why Every Patient with Cancer Needs a Strong Support System
Web Exclusives — November 1, 2021
Every person with cancer can benefit from a support system that can help manage the physical and emotional aspects of cancer care, as well as help with daily struggles. Read More ›

A Look at First-Line CLL Treatment in 2021
Web Exclusives — October 25, 2021
Currently, many effective, well-tolerated treatments exist, with high expectations for new drugs and regimens to be developed and approved in the near future. Read More ›

Analysis Shows Unmet Needs in Quality-of-Life Studies in Patients with CLL
Web Exclusives — October 25, 2021
A literature review found a set of physical, psychological, social, and spiritual topics that could be used to better educate patients throughout their CLL treatment journey. Read More ›

Reduced Efficacy of COVID-19 Vaccination in Immunocompromised Patients
Web Exclusives — October 25, 2021
COVID-19 vaccination is generally safe for immunocompromised patients, including those with CLL, although the efficacy is substantially lower than in healthy individuals. Read More ›

Early Results for a Promising New BCL-2 Inhibitor
Web Exclusives — October 25, 2021
Cell-based assays and animal data suggest that ZN-d5 may be a tolerable and effective treatment for patients with leukemias and lymphomas. Read More ›

Why It Helps to Share Your Cancer Story and How to Get Started
Web Exclusives — October 4, 2021
Sharing your cancer story can promote your sense of what’s truly important, giving you hope and strength in difficult times. Read More ›

Page 4 of 26